Clinical Outcomes
Ventilator Associated Pneumonia (VAP)
Ventilator-associated pneumonia (VAP) is a type of hospital-acquired pneumonia that occurs more than 48 hours after invasive mechanical ventilation (MV) via an endotracheal tube (ETT) or tracheostomy.
The number of Ventilator-associated pneumonia per 1000 ventilator days in selected ICUs is the standard measure for surveillance such as Mechanical Ventilatory Assistance for at least 2 consecutive days.
Malaysia Patient Safety Goal Standard ranged from 0.0-4.4 per 1,000 ventilators less than 10 per 1000 ventilator days
Infection Rate in ICU
Percentage of MRSA Infection at KPJ Ipoh Specialist Hospital from 2020 to 2022
Malaysia Patient Safety Goal Standard < 0.3%
Percentage of ESBL at KPJ Ipoh Specialist Hospital from 2020 to 2022
Malaysia Patient Safety Goal Standard < 0.3%
Percentage of Acinetobacter Baumannii at KPJ Ipoh Specialist Hospital from 2020 to 2022
List of Clinical Outcomes articles
- Mortality Rate during General Anaesthesia (GA), Local Anaesthesia (LA) and Regional anaesthesia
- Percutaneous Coronary Intervention (PCI)
- Coronary Artery Bypass Surgery (CABG)
- Rate of Complication for CT scan With IV Contrast Study and Rate of Complication for MRI Scan with IV Contrast Study
- O&G - LSCS Rate in KPJ Ipoh
- Chemotherapy extravasation
- Number of Total Knee Replacement (TKR) and Total Hip Replacement (THR) conducted
- Percentage of Unplanned Readmission for the Same Condition within 48 Hours of Discharge
- Percentage of Normal Dialysis, Patients Comply To KT/V 1.2
- Ventilator Associated Pneumonia (VAP)